Back to results
US 2016/0243080 A1Published application
Formulations of angiotensin receptor blockers
OwnerPeter M. Abadir, Jeremy D. Walstoninventors
Life of this patent
Estimating the term…
Abstract
Provided herein are pharmaceutical compositions for the treatment of wounds, including chronic wounds and diabetic ulcers. The pharmaceutical compositions, which comprise valsartan, inhibit angiotensin receptors in the wound bed. Also provided herein are methods of making the pharmaceutical compositions of the invention, and methods for treating wounds in patients in need thereof.
Claims34
A topical pharmaceutical composition, comprising:
- valsartan, in an amount from about 0.2% to about 2.5% by weight of the composition;
- and a pharmaceutically acceptable carrier material.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
21-26. (canceled)
28-36. (canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.